Report Categories
View AllRecent Articles
View All
MESO Mesoblast rises 077 percent in daily trading despite a narrow Q1 2026 EPS miss against analyst estimates
MDCX Medicus Pharma Q4 loss widens dramatically missing estimates by 430 shares fall 56
OEC Orion SA posts far wider Q4 2025 loss than estimates as shares rise on positive investor sentiment
What Brag House TBH disclosed about workforce costs Q4 2025 Earnings Fall Short